Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06374225 · ClinicalTrials.gov registry record · NA

Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention

A NA study of Critical Illness and Pathologic Processes, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT06374225 is a NA study of Critical Illness and Pathologic Processes that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 300 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06374225, a NA study of Critical Illness and Pathologic Processes, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

This study is a multicenter randomized controlled trial to determine the effectiveness of a closed loop/autonomous oxygen titration system (O2matic PRO100) to maintain normoxemia (goal range SpO2 90-96%, target 93%) during the first 72 hours of acute injury or illness, compared to standard provider-driven methods (manual titration with SpO2 target of 90-96%).

Conditions Studied

Critical Illness Pathologic Processes Wounds and Injury Disease Attributes

Interventions

  • DEVICE Automated Titration (O2matic)

Study Locations (4)

Colorado

  • University of Colorado - Aurora

North Carolina

  • Atrium Health Wake Forest Baptist Medical Center - Winston-Salem

Oregon

  • Oregon Health and Sciences University - Portland

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-04-29
Est. Completion 2026-05-01
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06374225

The ClinicalTrials.gov registry entry for NCT06374225 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (90% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Automated Titration (O2matic) is the first listed.

NCT06374225 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Colorado, North Carolina, Oregon.

Frequently Asked Questions

What is clinical trial NCT06374225 about?

NCT06374225 is a clinical study titled "Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention". This study is a multicenter randomized controlled trial to determine the effectiveness of a closed loop/autonomous oxygen titration system (O2matic PRO100) to maintain normoxemia (goal range SpO2 90-96%, target 93%) during the first 72 hours of acute injury or illness, compared to standard provider-...

What is the current status of trial NCT06374225?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-04-29. Estimated completion is 2026-05-01.

What conditions does trial NCT06374225 study?

This clinical trial studies the following conditions: Critical Illness, Pathologic Processes, Wounds and Injury, Disease Attributes.

What interventions are being tested in trial NCT06374225?

The interventions under investigation include: Automated Titration (O2matic) (DEVICE).

Who is sponsoring clinical trial NCT06374225?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06374225 being conducted?

This trial has 4 study locations across Colorado, North Carolina, Oregon, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Critical Illness

All registered trials for this condition

Pathologic Processes

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.